ES397035A1 - Antiinflammatory preparations - Google Patents

Antiinflammatory preparations

Info

Publication number
ES397035A1
ES397035A1 ES397035A ES397035A ES397035A1 ES 397035 A1 ES397035 A1 ES 397035A1 ES 397035 A ES397035 A ES 397035A ES 397035 A ES397035 A ES 397035A ES 397035 A1 ES397035 A1 ES 397035A1
Authority
ES
Spain
Prior art keywords
coprecipitate
lignosulfonate
inflammatory agent
antiinflammatory
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES397035A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of ES397035A1 publication Critical patent/ES397035A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A process for preparing a coprecipitate of an anti-inflammatory agent and a lignosulfonate, characterized in that an aqueous basic solution of an anti-inflammatory agent and a lignosulfonate is acidified, and then the coprecipitate is isolated by suitable means. (Machine-translation by Google Translate, not legally binding)
ES397035A 1970-11-16 1971-11-15 Antiinflammatory preparations Expired ES397035A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8999970A 1970-11-16 1970-11-16

Publications (1)

Publication Number Publication Date
ES397035A1 true ES397035A1 (en) 1975-03-01

Family

ID=22220596

Family Applications (2)

Application Number Title Priority Date Filing Date
ES397035A Expired ES397035A1 (en) 1970-11-16 1971-11-15 Antiinflammatory preparations
ES422331A Expired ES422331A1 (en) 1970-11-16 1974-01-16 Antiinflammatory preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES422331A Expired ES422331A1 (en) 1970-11-16 1974-01-16 Antiinflammatory preparations

Country Status (16)

Country Link
AT (1) AT313468B (en)
AU (1) AU461558B2 (en)
BE (1) BE775255A (en)
BR (1) BR7107569D0 (en)
CA (1) CA994241A (en)
CH (1) CH557177A (en)
DE (1) DE2156915A1 (en)
DK (1) DK132485C (en)
ES (2) ES397035A1 (en)
FI (1) FI51048C (en)
FR (1) FR2113976B1 (en)
GB (1) GB1345358A (en)
IE (1) IE36030B1 (en)
IL (1) IL38003A (en)
NL (1) NL7115198A (en)
ZA (1) ZA717652B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine

Also Published As

Publication number Publication date
DK132485B (en) 1975-12-15
ES422331A1 (en) 1976-06-01
DE2156915A1 (en) 1972-05-31
AU3492871A (en) 1973-05-03
FI51048C (en) 1976-10-11
FR2113976A1 (en) 1972-06-30
DK132485C (en) 1976-05-17
FI51048B (en) 1976-06-30
IL38003A0 (en) 1971-12-29
AT313468B (en) 1974-02-25
IE36030B1 (en) 1976-08-04
AU461558B2 (en) 1975-05-29
FR2113976B1 (en) 1975-10-31
NL7115198A (en) 1972-05-18
GB1345358A (en) 1974-01-30
CH557177A (en) 1974-12-31
IE36030L (en) 1972-05-16
CA994241A (en) 1976-08-03
IL38003A (en) 1974-06-30
BR7107569D0 (en) 1973-08-16
BE775255A (en) 1972-03-01
ZA717652B (en) 1972-10-25

Similar Documents

Publication Publication Date Title
ES324152A1 (en) Procedure for the obtaining of a fenilmercaptometanosulfonamida of fungytoxic effects. (Machine-translation by Google Translate, not legally binding)
ES413275A1 (en) Indenyl compounds
ES315410A1 (en) Procedure for the production of desamino-arg8-vasopresina. (Machine-translation by Google Translate, not legally binding)
ES397035A1 (en) Antiinflammatory preparations
ES299388A1 (en) Procedure for the production of a new polipepture and its derivatives (Machine-translation by Google Translate, not legally binding)
ES325472A1 (en) Procedure for the obtaining of de-amino-phe-arg-vasopresina. (Machine-translation by Google Translate, not legally binding)
ES421120A1 (en) Procedure for the preparation of N- (2-amino-3,5-dibromobenciliden) -trans-4-amino-ciclohexanol. (Machine-translation by Google Translate, not legally binding)
ES331182A1 (en) A procedure for the preparation of epsilon-caprolactone and its alcohol derivatives. (Machine-translation by Google Translate, not legally binding)
ES407523A1 (en) Natiinflammatory agents
ES294357A1 (en) Procedure for the obtaining of new nonapeptures (Machine-translation by Google Translate, not legally binding)
ES431083A1 (en) Alanine derivatives and their production
ES329851A1 (en) Procedure for the preparation of new antibiotics. (Machine-translation by Google Translate, not legally binding)
ES403003A1 (en) Method of preparing 2-methoxy-n-n-ethylpyrrolidin-2-yl- methyl-5-sulphamoyl-benzamide
ES328594A1 (en) A procedure for the preparation of eritromycin glutamate. (Machine-translation by Google Translate, not legally binding)
ES405154A3 (en) Procedure for obtaining acid, 3, 4, 5 trimetoxibenzoilamidocarboxilico and their salts. (Machine-translation by Google Translate, not legally binding)
ES413274A1 (en) A procedure for the preparation of an indenilactic acid derivative. (Machine-translation by Google Translate, not legally binding)
ES293226A1 (en) Procedure for the preparation of a pigment based on the beta form of quinacridone (Machine-translation by Google Translate, not legally binding)
ES320392A3 (en) Procedure for the obtaining of hormonal derivatives. (Machine-translation by Google Translate, not legally binding)
ES319122A1 (en) A procedure for preparing an antidyardaric complex of bismuto and chlorohidroxyquinoline. (Machine-translation by Google Translate, not legally binding)
ES274035A1 (en) Procedure for the preparation of N-methyl-efedrine beta-canfosulfonate (Machine-translation by Google Translate, not legally binding)
ES407124A2 (en) A procedure for obtaining a doxidicline salt. (Machine-translation by Google Translate, not legally binding)
ES323030A1 (en) Procedure for the obtaining of a hydrosoluble derivative of pirazolidine. (Machine-translation by Google Translate, not legally binding)
ES310184A1 (en) Procedure for the preparation of a new derivative of pirazolidine-hexametilenimina with therapeutic properties. (Machine-translation by Google Translate, not legally binding)
ES314562A1 (en) Procedure for the obtaining of halogeno-alcanos thiocarbamate. (Machine-translation by Google Translate, not legally binding)
ES263915A3 (en) Procedure for obtaining hormones and vitamins, especially b 12 of slow effect via via injectable (Machine-translation by Google Translate, not legally binding)